Microbiome–Metabolome Crosstalk as a Driver of COVID-19 Severity

[Institutional Review Board Statement] The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Clinical Research Ethics Committee of Granada (CEIC) (ID of the approval omicovid-19 1133-N-20) on 18 June 2020. The samples were managed by the ibs.GRA...

Descripción completa

Detalles Bibliográficos
Autores: Diez-Echave, Patricia, Rodríguez-Sojo, María Jesús, Martin-Castaño, Benita, Hidalgo-García, Laura, Ruiz-Malagon, Antonio Jesús, Molina-Tijeras, José Alberto, Redruello Romero, Anaïs, Martínez-Zaldívar, Margarita, Mota, Emilio, Cobo, Fernando, Alvarez-Estevez, Marta, García, Federico, Morales-García, Concepción, Merlos, Silvia, García-Flores, Paula, Colmenero-Ruiz, Manuel, Nuñez, María, Ruiz-Sancho, Andrés, Rodríguez-Cabezas, María Elena, Gallego, Ángel Carazo, Fernández-Varón, Emilio, Pérez del Palacio, José, Martin Ibáñez, Javier, García-García, Jorge, Morón, Rocío, Rodríguez-Nogales, Alba, Gálvez, Julio
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2026
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/421510
Acceso en línea:http://hdl.handle.net/10261/421510
Access Level:acceso abierto
Palabra clave:Biomarkers
COVID-19 severity
Metabolomic
Microbiome
SARS-CoV-2
Descripción
Sumario:[Institutional Review Board Statement] The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Clinical Research Ethics Committee of Granada (CEIC) (ID of the approval omicovid-19 1133-N-20) on 18 June 2020. The samples were managed by the ibs.GRANADA Biobank follows the protocols approved by the Andalusian Biomedical Research Ethics Coordinating Committee.

Similares en LA Referencia